
	Three months ended March 31, 2026						Three months ended March 31, 2025
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,675,413	$		$	1,675,413	$	1,609,018	$		$	1,609,018
Medicaid and Managed Medicaid	212,830				212,830		206,509				206,509
Other government	92,940		248,179		341,119		76,746		209,747		286,493
Commercial	954,243		109,664		1,063,907		924,888		87,819		1,012,707
Other revenues:
Medicare and Medicare Advantage			108,506		108,506				98,954		98,954
Medicaid and Managed Medicaid			—		—				2		2
Commercial			3,648		3,648				2,701		2,701
Other(1)	6,275		27,610		33,885		6,008		15,599		21,607
Eliminations of intersegment revenues	(20,472)		(3,288)		(23,760)		(11,734)		(2,728)		(14,462)
Total	$	2,921,229	$	494,319	$	3,415,548	$	2,811,435	$	412,094	$	3,223,529

(1) Consists primarily of management service fees in the Company's U.S. dialysis business and research fees, management fees, and other non-patient service revenues in the Other - ancillary services businesses.